Dramatic Relief From A Multitude Of Ill-Health Symptoms From
Elimination Diets Audit of Patient Study Involving 'Finger-Stick' Food Intolerance Test Published in Prestigious Medical Journal
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-05-2002/0001795148&EDATE=
PR Newswire – According to an independent audit conducted by the
Department of Health Studies at the University of York, on behalf of the British Allergy Foundation, patients experienced dramatic relief from a multitude of ill-health symptoms as a direct result of eliminating problem foods from their diet. The study, conducted by the Townsend Letter for Doctors and Patients, concluded that long-term chronic illnesses can be improved and billions of dollars saved if patients follow the results of the "finger-stick" IgG ELISA food intolerance test provided by York Nutritional Laboratories.
The British Allergy Foundation commissioned the study to examine the usefulness of York Nutritional Laboratories' test for those suffering from chronic illnesses, such as eczema, irritable bowel syndrome, asthma, arthritis and migraine headache. Results confirmed that York Nutritional Laboratories' own research of over 2500 patients was an accurate reflection of the positive health benefits gained by their patients. According to the study, over three quarters of patients had reported significant improvement in their health after adhering to the recommendations of their food intolerance test.
According to Muriel Simmons, Chief Executive of the British
Allergy Foundation, "A very high percentage of people suffer from food
intolerance, which produces a very wide range of symptoms and often causes problems over many years. As a result of the number of people contacting us with these problems we decided to commission a review of the anecdotal evidence that the IgG tests conducted by York Nutritional Laboratories assisted people in identifying the foods causing their problems ... the results of this audit made it very clear that if the foods identified were eliminated from the diet, tremendous benefits were achieved. The evidence for this type of food intolerance testing is simply too strong to ignore."
Professor Trevor Sheldon, Head of the Department of Health Studies, concluded in the audit that over 70% of patients that benefited from the test reported continued health improvements one year later.
John Kernohan, Director of York Nutritional Laboratories, Inc. was delighted with the recognition given by the British Allergy Foundation, "Professor Sheldon confirmed the health benefits our patients report from following the recommendations provided by our foodSCAN food intolerance test.
The study's conclusions reinforce our determination to continue our research into the role of IgG-mediated food allergy (food intolerance) and its impact on those suffering from chronic ill-health conditions."
No Evidence For Linkage Of Liability To Autism to HOXA1. . .
In a sample from the CPEA network.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12210285&dopt=Abstract
Devlin B, Bennett P, Cook EH Jr, Dawson G, Gonen D, Grigorenko EL,
McMahon W, Pauls D, Smith M, Spence MA, Schellenberg GD.
Department of Psychiatry, University of Pittsburgh, School of Medicine,
Pittsburgh, Pennsylvania.
A recent study by Ingram et al. [2000b: Teratology 62:393-405] suggests a (His)73(Arg) polymorphism (A:G) in HOXA1 contributes substantially to a liability for autism.
Using 68 individuals diagnosed with Autism Spectrum Disorders,
they found a significant dearth of G homozygotes and biased transmission of G alleles from parents to affected offspring, especially from mothers.
Because the connection between HOXA1 and liability to autism is compelling, we attempted to replicate their finding using a larger, independent sample from the Collaborative Programs of Excellence in
Autism (CPEA) network.
In our data, genotype frequencies conform to Hardy-Weinberg equilibrium; allele transmissions meet Mendelian expectations; and there is no obvious sex-biased allele transmission.
Based on our sample size, calculations suggest that we would have
at least 95% power to detect linkage and association even if the A:G polymorphism were to account for only 1% of the heritability of autism.
Therefore, although we cannot exclude the possibility that the samples in the two studies are intrinsically different, our data from our sample argue against a major role for HOXA1 (His)73(Arg) in liability to autism.
Copyright 2002 Wiley-Liss, Inc.
PMID: 12210285 [PubMed - as supplied by publisher]
Schizophrenia and Other Mental Disorders Require Long-Term Adoptive Immunotherapy.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12208201&dopt=Abstract
Wank R. University of Muenchen, Muenchen, Germany
Many different microbial factors seem to contribute to the pathogenesis of schizophrenic and other psychiatric disorders.
Activation of all T lymphocytes reactivates those downregulated
by low-grade chronic infections and restores equilibrium in immune cell subpopulations.
Different immune cell subpopulations express different
neurotrophin receptors and produce different cytokines, particularly brain-derived neurotrophin (BDNF) and neurotrophin 3 (NT3) [M.Besser, R. Wank, J. Immunol. 162 (1998) 6303-6306] that appear to play a key role in schizophrenic and bipolar disorders [E. Jonsson, S. Brene, X.R. Zhang, et al., Acta Psychiatr.Scand. 95 (1997) 414-419; R.S. Duman, Arch. Gen. Psychiatry 54 (1997) 597-606; J.A. Siuciak, D.R. Lewis, S.J Wiegand, R.M. Lindsay, Pharmacol. Biochem. Be 56 (1997) 131-137].
The hypothesis that adoptive immunotherapy is effective in
psychiatric disorders will be supported by three case reports, in a patient with bipolar disorder, a patient with schizophrenia, and a patient with autism.
PMID: 12208201 [PubMed - as supplied by publisher]
Live Virus Vaccination Near A Pregnancy: Flawed Policies, Tragic
Results.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12208154&dopt=Abstract
Yazbak F, Yazbak K.
TL Autism Research, West Falmouth, Massachusetts, USA
Vaccination of women with live virus vaccines around conception has always been contraindicated by the Center for Disease Control and Prevention (CDC) and the vaccine manufacturer because of potential risks to the fetus.
Nevertheless this dangerous practice occurs and is associated with maternal health problems and a very high incidence of early-onset
autism in the children.Postpartum vaccination with live virus vaccines has been recommended by the CDC, and described as 'convenient' by the vaccine manufacturer.
This 'routine practice' may lead to health and is also associated with many health and obstetrical problems in the recipient, and is frequently associated with autism in both current and future children.
Re-vaccination often fails to produce immunity, the very reason for which it was recommended.
PMID: 12208154 [PubMed - as supplied by publisher]
new MMR autism link
http://icwales.icnetwork.co.uk/0100news/0200wales/page.cfm?objectid=12172694&method=full&siteid=50082
(This echoes the work of Dr. Bradstreet here in the States who discovered measles virus in the spinal fluid of several autistic kids.)
